Whales with a lot of money to spend have taken a noticeably bearish stance on AbbVie.
Looking at options history for AbbVie ABBV we detected 10 trades.
If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 80% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $173,757 and 6, calls, for a total amount of $436,535.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $120.0 and $180.0 for AbbVie, spanning the last three months.
Volume & Open Interest Development
In today's trading context, the average open interest for options of AbbVie stands at 1533.62, with a total volume reaching 4,545.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AbbVie, situated within the strike price corridor from $120.0 to $180.0, throughout the last 30 days.
AbbVie 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| ABBV | CALL | SWEEP | NEUTRAL | 02/16/24 | $170.00 | $152.6K | 5.8K | 2.6K |
| ABBV | CALL | SWEEP | BEARISH | 02/16/24 | $170.00 | $117.8K | 5.8K | 1.3K |
| ABBV | PUT | SWEEP | BEARISH | 01/16/26 | $135.00 | $68.6K | 46 | 58 |
| ABBV | CALL | SWEEP | BEARISH | 06/20/25 | $165.00 | $50.1K | 38 | 41 |
| ABBV | CALL | TRADE | BEARISH | 02/16/24 | $167.50 | $47.0K | 1.2K | 205 |
About AbbVie
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Where Is AbbVie Standing Right Now?
- With a trading volume of 1,195,626, the price of ABBV is up by 0.28%, reaching $165.39.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 2 days from now.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AbbVie options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
